Histotripsy is a new, FDA-approved, minimally invasive technique that destroys liver tumors using high-frequency ultrasound ...

Dan Bloomfield, MD, chief medical officer, Anthos, walks through promising findings demonstrating the efficacy of abelacimab, ...

Rachel Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with ...

The rate of frailty among patients with multiple sclerosis (MS) ranges from 17% to 66% among ambulatory patients, and frailty ...

A national survey of Canadian hematologists reveals gaps and variability in supportive care strategies for older adults with ...

Based on their findings, the researchers suggest the integration of automated measures to identify interventricular septal ...

Among the most-read coverage for the annual meeting were presentations on the potential and costs of cell and gene therapies, ...

Researchers study long-term safety of lentiviral gene therapy in primates, finding no evidence of somatic mutations or ...

Cognitive and behavioral techniques can improve physical function and overall well-being in patients with long COVID.

EDO51, an investigational therapy for Duchenne muscular dystrophy (DMD), and is still ongoing in the United Kingdom.

From imaging innovations to new treatment approvals, 2024 brought advancements in Duchenne muscular dystrophy care and ...

A panelist discusses how continuous glucose monitoring (CGM) technology can help overcome therapeutic inertia and key barriers to glycemic control in type 2 diabetes (T2D) patients by providing ...